CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

CRIPTO (CR-1, TDGF1) is a cell surface/secreted oncoprotein actively involved in development and cancer. Here, we report that high expression of CRIPTO correlates with poor survival in stratified risk groups of prostate cancer (PCa) patients. CRIPTO and its signaling partner glucose-regulated protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoni, E, Chen, L, Karkampouna, S, Granchi, Z, Verhoef, E I, La Manna, F, Kelber, J, Pelger, R C M, Henry, M D, Snaar-Jagalska, E, van Leenders, G J L H, Beimers, L, Kloen, P, Gray, P C, van der Pluijm, G, Kruithof-de Julio, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562855/
https://www.ncbi.nlm.nih.gov/pubmed/28394345
http://dx.doi.org/10.1038/onc.2017.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562855/
https://www.ncbi.nlm.nih.gov/pubmed/28394345
http://dx.doi.org/10.1038/onc.2017.87

Ejemplares similares